Roche (RHHBY.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec11

UBS analyst maintains buy rating on Roche Holding

09:56

Roche Obtains CE Mark Certification for Expanding Its Automated Mass Spectrometry Platform

06:03

Dec10

Roche's Breast Cancer Drug Giredestrant Shows Significant Reduction in Recurrence Risk in Clinical Trials

13:17

Dec9

Roche Launches New PCR Test cobas BV/CV for Vaginal Infections

06:13

Roche's Gazyva/Gazyvaro Approved by European Commission for Lupus Nephritis Treatment

06:00

Dec8

Roche's Lunsumio® Shows Positive Progress in Lymphoma Treatment with Combination Therapy

21:30

Schedules & Filings

Schedules

Filings

Jan29

Earning Release(EST)

FY2025 Annual Earning Release

Jul24

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.91 B, Net Income 4.632 B, EPS 0.7212

Mar28

Distribution Plan(EST)

Cash dividend 1.3629 USD

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More